When COVID-19 forced Sightsavers and partners to pause some NTD programmes in Africa, we worked quickly to adapt and restart them as quickly and safely as possible.
Together with ministries and other organisations, Sightsavers has been working on COVID-19 behavioural messaging campaigns in nine African countries to reach millions of people across radio, television, social media and via billboards and leaflets.
Resuming mass drug administration programmes to treat neglected tropical diseases is essential to reach WHO 2021-2030 NTD Roadmap targets, according to a new report.
With the COVID-19 pandemic showing no signs of abating, resuming neglected tropical disease activities, particularly mass drug administration, is vital in achieving WHO Roadmap targets.
The Ascend Learning and Innovation Fund is funding projects to accelerate the control and elimination efforts of neglected tropical diseases.
RAMA is a new risk assessment and mitigation action tool enabling us and government partners to mitigate the risk of spreading COVID-19 and restart treatment.
Moses Chege, Sightsavers Kenya country director, explains how Sightsavers and partners were able to reach the worst-affected people suffering from trachoma.
Nigeria is the first Sightsavers-supported country to resume treatments for neglected tropical diseases (NTDs) since April due to COVID-19.
Sightsavers and partners delivered 11.7 million trachoma treatments and carried out nearly 32,000 trichiasis surgeries in two years under the Commonwealth Fund.
A Sightsavers-led programme in Africa has surpassed several of its first-year targets as it delivers more than 127 million drug treatments for five debilitating neglected tropical diseases (NTDs).